Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PSA | Common Stock | Options Exercise | $7.6M | +50K | +28.2% | $152.01 | 227K | Aug 23, 2021 | Direct | F1 |
transaction | PSA | Common Stock | Sale | -$16.1M | -50K | -22% | $321.97 | 177K | Aug 23, 2021 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PSA | Stock Option (right to buy) | Options Exercise | $0 | -50K | -50% | $0.00 | 50K | Aug 23, 2021 | Common Stock | 50K | $152.01 | Direct | F3 |
Id | Content |
---|---|
F1 | Includes 39,900 restricted stock units and 1,324 deferred stock units. |
F2 | Represents weighted average price. These shares were sold at prices ranging between $321.435 and $322.41. Full information regarding the number of shares sold at each separate price will be provided by the reporting person upon request to the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer. |
F3 | Stock Options granted pursuant to the 2007 Equity and Performance-Based Compensation Plan. Options vested in 5 equal annual installments beginning 1 year from grant date. |